Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis
- PMID: 24575020
- PMCID: PMC3934805
- DOI: 10.1159/000357802
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis
Abstract
In the present study, we report an extremely rare case of a 31-year-old woman with neuroblastoma arising in an ovarian cystic teratoma. We analyzed the expression of activating receptors on natural killer (NK) cells derived from the patient's peripheral blood and peritoneal fluid. In addition, we investigated the presence of specific ligands recognized by different NK cell receptors on tumor cells. We show that NK cells isolated from peritoneal fluid expressed certain triggering receptors including DNAM-1 (CD226) and CD16 with lower intensity as compared to peripheral blood NK cells. Remarkably, at variance with most cases of childhood neuroblastoma, the tumor cells from this patient expressed substantial amounts of HLA class-I molecules. These molecules are known to be protective against NK cell-mediated lysis. In addition, neuroblastoma cells expressed B7-H3 (CD276), another surface molecule that inhibits NK cell function. Finally, this tumor did not express the PVR (CD155) and nectin-2 (CD112) ligands for the DNAM-1 activating NK receptor, which plays a crucial role in NK/neuroblastoma interactions. Altogether, these findings indicate that the neuroblastoma cells of this patient express an NK-resistant surface phenotype, which is at least in part similar to that previously described in a fraction of childhood neuroblastoma.
Keywords: Activating natural killer receptors; Natural killer cells; Neuroblastoma; Ovarian cancer.
Figures


Similar articles
-
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.J Exp Med. 2003 Aug 18;198(4):557-67. doi: 10.1084/jem.20030788. Epub 2003 Aug 11. J Exp Med. 2003. PMID: 12913096 Free PMC article.
-
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.Front Immunol. 2020 Jan 28;11:40. doi: 10.3389/fimmu.2020.00040. eCollection 2020. Front Immunol. 2020. PMID: 32082316 Free PMC article.
-
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.Mol Immunol. 2005 Feb;42(4):463-9. doi: 10.1016/j.molimm.2004.07.028. Mol Immunol. 2005. PMID: 15607800
-
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.Cancers (Basel). 2019 Jun 23;11(6):877. doi: 10.3390/cancers11060877. Cancers (Basel). 2019. PMID: 31234588 Free PMC article. Review.
-
DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.Immunol Cell Biol. 2014 Mar;92(3):237-44. doi: 10.1038/icb.2013.95. Epub 2013 Dec 17. Immunol Cell Biol. 2014. PMID: 24343663 Review.
Cited by
-
Features of Memory-Like and PD-1(+) Human NK Cell Subsets.Front Immunol. 2016 Sep 14;7:351. doi: 10.3389/fimmu.2016.00351. eCollection 2016. Front Immunol. 2016. PMID: 27683578 Free PMC article. Review.
-
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.Oncoimmunology. 2015 Jan 22;4(4):e1001224. doi: 10.1080/2162402X.2014.1001224. eCollection 2015 Apr. Oncoimmunology. 2015. PMID: 26137398 Free PMC article.
-
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy.Signal Transduct Target Ther. 2020 Oct 29;5(1):250. doi: 10.1038/s41392-020-00348-8. Signal Transduct Target Ther. 2020. PMID: 33122640 Free PMC article. Review.
-
Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells.Cancer Immunol Immunother. 2018 Apr;67(4):575-587. doi: 10.1007/s00262-017-2112-x. Epub 2018 Jan 3. Cancer Immunol Immunother. 2018. PMID: 29299659 Free PMC article.
-
NK Cell-Based Immune Checkpoint Inhibition.Front Immunol. 2020 Feb 13;11:167. doi: 10.3389/fimmu.2020.00167. eCollection 2020. Front Immunol. 2020. PMID: 32117298 Free PMC article. Review.
References
-
- Kleinman GM, Young RH, Scully RE. Primary neuroectodermal tumors of the ovary. A report of 25 cases. Am J Surg Pathol. 1993;17:764–778. - PubMed
-
- Morovic A, Damjanov I. Neuroectodermal ovarian tumors: a brief overview. Histol Histopathol. 2008;23:765–771. - PubMed
-
- Muhlstein J, Rodriguez-Dahlhoff S, Marie B, Fouyssac F. Primary ovarian neuroblastoma. J Pediatr Adolesc Gynecol. 2010;23:263–266. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials